12-Month Teriparatide Treatment Reduces New Vertebral Compression Fractures Incidence And Back Pain And Improves Quality Of Life After Percutaneous Kyphoplasty In Osteoporotic Women

References

• Alexandra H. [Osteoporosis: prevention, diagnosis and therapy]. Medizinische Monatsschrift Für Pharmazeuten. 2002;25(5):164.12050922
   PubMedGoogle Scholar
• Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. Jama. 2009;301(5):513–521.19190316
   PubMed Web of Science ®Google Scholar
• Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporosis Int. 2006;17(12):1726–1733.
   PubMed Web of Science ®Google Scholar
• Atalay B, Caner H, Gokce C, Altinors N. Kyphoplasty: 2 years of experience in a neurosurgery department. Surg Neurol. 2005;64(Suppl 2):S72–76.16256847
   PubMedGoogle Scholar
• Lieberman I, Reinhardt MK. Vertebroplasty and kyphoplasty for osteolytic vertebral collapse. Clin Orthop Relat Res. 2003;415 Suppl:S176–186.
   Web of Science ®Google Scholar
• Georgy BA. Interventional techniques in managing persistent pain after vertebral augmentation procedures: a retrospective evaluation. Pain Physician. 2007;10(5):673–676.17876364
   PubMedGoogle Scholar
• Nagad P, Rawall S, Kundnani V, Mohan K, Patil SS, Nene A. Postvertebroplasty instability. J Neurosurg Spine. 2012;16(4):387–393. doi:10.3171/2011.12.SPINE1167122225486
   PubMed Web of Science ®Google Scholar
• Boger A, Heini P, Windolf M, Schneider E. Adjacent vertebral failure after vertebroplasty: a biomechanical study of low-modulus PMMA cement. Eur Spine J. 2007;16(12):2118–2125. doi:10.1007/s00586-007-0473-017713795
   PubMed Web of Science ®Google Scholar
• Lin CC, Chen IH, Yu TC, Chen A, Yen PS. New symptomatic compression fracture after percutaneous vertebroplasty at the thoracolumbar junction. AJNR Am J Neuroradiol. 2007;28(6):1042–1045. doi:10.3174/ajnr.A052017569953
   PubMed Web of Science ®Google Scholar
• Syed MI, Patel NA, Jan S, Harron MS, Morar K, Shaikh A. New symptomatic vertebral compression fractures within a year following vertebroplasty in osteoporotic women. AJNR Am J Neuroradiol. 2005;26(6):1601–1604.15956537
   PubMed Web of Science ®Google Scholar
• Boswell MV, Trescot AM, Sukdeb D, et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007;10(1):7–111.17256025
   PubMedGoogle Scholar
• Taylor RS, Taylor RJ, Fritzell P. Balloon kyphoplasty and vertebroplasty for vertebral compression fractures: a comparative systematic review of efficacy and safety. Spine. 2006;31(23):2747–2755. doi:10.1097/01.brs.0000244639.71656.7d17077747
   PubMed Web of Science ®Google Scholar
• Lee BG, Choi JH, Kim DY, Choi WR, Lee SG, Kang CN. Risk factors for newly developed osteoporotic vertebral compression fractures following treatment for osteoporotic vertebral compression fractures. Spine J. 2019;19(2):301–305.
   Web of Science ®Google Scholar
• Cosman F, de Beur SJ, LeBoff MS, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis Int. 2014;25(10):2359–2381. doi:10.1007/s00198-014-2794-2
   PubMed Web of Science ®Google Scholar
• Vondracek SF, Linnebur SA. Diagnosis and management of osteoporosis in the older senior. Clin Interv Aging. 2009;4:121–136.19503775
   PubMed Web of Science ®Google Scholar
• Vandenbroucke A, Luyten FP, Flamaing J, Gielen E. Pharmacological treatment of osteoporosis in the oldest old. Clin Interv Aging. 2017;12:1065–1077. doi:10.2147/CIA.S13102328740372
   PubMed Web of Science ®Google Scholar
• Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344(19):1434–1441. doi:10.1056/NEJM20010510344190411346808
   PubMed Web of Science ®Google Scholar
• Gallagher JC, Genant HK, Crans GG, Vargas SJ, Krege JH. Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures. J Clin Endocrinol Metab. 2005;90(3):1583–1587. doi:10.1210/jc.2004-082615613428
   PubMed Web of Science ®Google Scholar
• Fahrleitner-Pammer A, Langdahl BL, Marin F, et al. Fracture rate and back pain during and after discontinuation of teriparatide: 36-month data from the European Forsteo Observational Study (EFOS). Osteoporosis Int. 2011;22(10):2709–2719. doi:10.1007/s00198-010-1498-5
   PubMed Web of Science ®Google Scholar
• Yan L, Chang Z, Xu Z, Liu T, He B, Hao D. Biomechanical effects of bone cement volume on the endplates of augmented vertebral body: a three-dimensional finite element analysis. Chin Med J. 2014;127(1):79–84.24384428
   PubMed Web of Science ®Google Scholar
• Heary RF, Parvathreddy NK, Agarwal N. Biomechanical analysis of range of motion and failure characteristics of osteoporotic spinal compression fractures in human cadaver. Indian J Orthop. 2017;51(6):672–676. doi:10.4103/ortho.IJOrtho_147_1629200483
   PubMed Web of Science ®Google Scholar
• Luo N, Liu G, Li M, Guan H, Jin X, Rand-Hendriksen K. Estimating an EQ-5D-5L value set for China. Value Health. 2017;20(4):662–669. doi:10.1016/j.jval.2016.11.01628408009
   PubMed Web of Science ®Google Scholar
• Luo N, Li M, Liu GG, Lloyd A, de Charro F, Herdman M. Developing the Chinese version of the new 5-level EQ-5D descriptive system: the response scaling approach. Qual Life Res. 2013;22(4):885–890. doi:10.1007/s11136-012-0200-022622627
   PubMed Web of Science ®Google Scholar
• Diggle PJ. Introduction to Liang and Zeger (1986) Longitudinal Data Analysis Using Generalized Linear Models. Breakthroughs in Statistics 1997; 463–482.
   Google Scholar
• Langdahl BL, Ljunggren O, Benhamou CL, et al. Fracture rate, quality of life and back pain in patients with osteoporosis treated with teriparatide: 24-month results from the extended forsteo observational study (ExFOS). Calcif Tissue Int. 2016;99(3):259–271. doi:10.1007/s00223-016-0143-527137783
   PubMed Web of Science ®Google Scholar
• Natarajan RCLJPR. Modeling covariance strueture in the analysis of repeated measures data. Statistics in Medicine 2000;19(13):1793.
   Google Scholar
• Lin H, Bao LH, Zhu XF, Qian C, Chen X, Han ZB. Analysis of recurrent fracture of a new vertebral body after percutaneous vertebroplasty in patients with osteoporosis. Orthop Surg. 2010;2(2):119–123. doi:10.1111/j.1757-7861.2010.00074.x22009926
   PubMedGoogle Scholar
• Tanigawa N, Kariya S, Komemushi A, et al. Percutaneous vertebroplasty for osteoporotic compression fractures: long-term evaluation of the technical and clinical outcomes. AJR Am J Roentgenol. 2011;196(6):1415–1418. doi:10.2214/AJR.10.558621606307
   PubMed Web of Science ®Google Scholar
• Farrokhi MR, Alibai E, Maghami Z. Randomized controlled trial of percutaneous vertebroplasty versus optimal medical management for the relief of pain and disability in acute osteoporotic vertebral compression fractures. J Neurosurg Spine. 2011;14(5):561–569. doi:10.3171/2010.12.SPINE1028621375382
   PubMed Web of Science ®Google Scholar
• Han SL, Wan SL, Li QT, et al. Is vertebroplasty a risk factor for subsequent vertebral fracture, meta-analysis of published evidence? Osteoporosis Int. 2015;26(1):113–122. doi:10.1007/s00198-014-2848-5
   Web of Science ®Google Scholar
• Yi X, Lu H, Tian F, et al. Recompression in new levels after percutaneous vertebroplasty and kyphoplasty compared with conservative treatment. Arch Orthop Trauma Surg. 2014;134(1):21–30. doi:10.1007/s00402-013-1886-324287674
   PubMed Web of Science ®Google Scholar
• Cooper C, Jakob F, Chinn C, et al. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). Osteoporosis Int. 2008;19(4):493–501. doi:10.1007/s00198-007-0488-8
   Web of Science ®Google Scholar
• Yu W, Xu W, Jiang X. et al. Risk factors for recollapse of the augmented vertebrae after percutaneous vertebral augmentation: a systematic review and meta-analysis. World Neurosurg;2018 119–129. doi:10.1016/j.wneu.2017.12.019
   Web of Science ®Google Scholar
• Barr JD, Barr MS, Lemley TJ, McCann RM. Percutaneous vertebroplasty for pain relief and spinal stabilization. Spine. 2000;25(8):923–928. doi:10.1097/00007632-200004150-0000510767803
   PubMed Web of Science ®Google Scholar
• Nuchterlein M, Bail HJ. [A rare complication of kyphoplasty is PMMA-cement loosening - case report and literature review]. Z Orthop Unfall. 2013;151(5):463–467. doi:10.1055/s-0033-135086124129715
   PubMed Web of Science ®Google Scholar
• Chitre MM, Hayes W. 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. J Managed Care Pharm. 2008;14(3):281–290. doi:10.18553/jmcp.2008.14.3.281
   Google Scholar
• Hey HW, Tan JH, Tan CS, Tan HM, Lau PH, Hee HT. Subsequent vertebral fractures post cement augmentation of the thoracolumbar spine: does it correlate with level-specific bone mineral density scores? Spine. 2015;40(24):1903–1909. doi:10.1097/BRS.000000000000106626208228
   PubMed Web of Science ®Google Scholar
• Gallacher SJ, Dixon T. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review. Calcif Tissue Int. 2010;87(6):469–484. doi:10.1007/s00223-010-9420-x20872215
   PubMed Web of Science ®Google Scholar
• Oswald AJ, Berg J, Milne G, Ralston SH. Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice. Calcif Tissue Int. 2014;94(2):176–182. doi:10.1007/s00223-013-9788-524026567
   PubMed Web of Science ®Google Scholar
• Saag KG, Zanchetta JR, Devogelaer JP, et al. Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial. Arthritis Rheum. 2009;60(11):3346–3355. doi:10.1002/art.2487919877063
   PubMed Web of Science ®Google Scholar
• Nevitt MC, Chen P, Dore RK, et al. Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporosis Int. 2006;17(2):273–280. doi:10.1007/s00198-005-2013-2
   PubMed Web of Science ®Google Scholar
• Nevitt MC, Chen P, Kiel DP, et al. Reduction in the risk of developing back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis. Osteoporosis Int. 2006;17(11):1630–1637. doi:10.1007/s00198-006-0177-z
   Web of Science ®Google Scholar
• Borgstrom F, Zethraeus N, Johnell O, et al. Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporosis Int. 2006;17(5):637–650. doi:10.1007/s00198-005-0015-8
   PubMed Web of Science ®Google Scholar
• Catalano A, Martino G, Morabito N, et al. Pain in osteoporosis: from pathophysiology to therapeutic approach. Drugs Aging. 2017;34(10):755–765. doi:10.1007/s40266-017-0492-428980156
   PubMed Web of Science ®Google Scholar
• Langdahl BL, Rajzbaum G, Jakob F, et al. Reduction in fracture rate and back pain and increased quality of life in postmenopausal women treated with teriparatide: 18-month data from the European Forsteo Observational Study (EFOS). Calcif Tissue Int. 2009;85(6):484–493. doi:10.1007/s00223-009-9299-619823760
   PubMed Web of Science ®Google Scholar
• Foster SA, Foley KA, Meadows ES, et al. Adherence and persistence with teriparatide among patients with commercial, medicare, and medicaid insurance. Osteoporosis Int. 2011;22(2):551–557. doi:10.1007/s00198-010-1297-z
   Web of Science ®Google Scholar
• Layton KF, Thielen KR, Koch CA, et al. Vertebroplasty, first 1000 levels of a single center: evaluation of the outcomes and complications. AJNR Am J Neuroradiol. 2007;28(4):683–689.17416821
   PubMed Web of Science ®Google Scholar
• Wang H, Sribastav SS, Ye F, et al. Comparison of percutaneous vertebroplasty and balloon kyphoplasty for the treatment of single level vertebral compression fractures: a meta-analysis of the literature. Pain Physician. 2015;18(3):209.26000665
   PubMed Web of Science ®Google Scholar
• Salaffi F, Cimmino MA, Malavolta N, et al. The burden of prevalent fractures on health-related quality of life in postmenopausal women with osteoporosis: the IMOF study. J Rheumatol. 2007;34(7):1551–1560.17516618
   PubMed Web of Science ®Google Scholar